IL327216A - שיטה לטיפול בזאבת - Google Patents

שיטה לטיפול בזאבת

Info

Publication number
IL327216A
IL327216A IL327216A IL32721626A IL327216A IL 327216 A IL327216 A IL 327216A IL 327216 A IL327216 A IL 327216A IL 32721626 A IL32721626 A IL 32721626A IL 327216 A IL327216 A IL 327216A
Authority
IL
Israel
Prior art keywords
treating lupus
lupus
treating
Prior art date
Application number
IL327216A
Other languages
English (en)
Inventor
Melanie Harrison
Original Assignee
Bristol Myers Squibb Co
Melanie Harrison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co, Melanie Harrison filed Critical Bristol Myers Squibb Co
Publication of IL327216A publication Critical patent/IL327216A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL327216A 2023-10-02 2024-10-01 שיטה לטיפול בזאבת IL327216A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363587308P 2023-10-02 2023-10-02
PCT/US2024/049377 WO2025075944A1 (en) 2023-10-02 2024-10-01 A method of treating lupus

Publications (1)

Publication Number Publication Date
IL327216A true IL327216A (he) 2026-05-01

Family

ID=93288941

Family Applications (1)

Application Number Title Priority Date Filing Date
IL327216A IL327216A (he) 2023-10-02 2024-10-01 שיטה לטיפול בזאבת

Country Status (3)

Country Link
AU (1) AU2024356361A1 (he)
IL (1) IL327216A (he)
WO (1) WO2025075944A1 (he)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10071079B2 (en) 2016-06-29 2018-09-11 Bristol-Myers Squibb Company [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
CA3181964A1 (en) * 2020-06-11 2021-12-16 Gary L. Schieven Tlr7 inhibitor in combination with prednisolone or hydroxychloroquine for treating cutaneous lupus erythematosus

Also Published As

Publication number Publication date
WO2025075944A1 (en) 2025-04-10
AU2024356361A1 (en) 2026-04-02

Similar Documents

Publication Publication Date Title
GB202412728D0 (en) A method of precision treatment
IL325649A (he) שיטה לטיפול בדיכאון באמצעות סלטורקסנט
CA3306146A1 (en) A method of treating lupus
EP4401839A4 (en) METHOD OF TREATMENT OF MULTIPLE MYELOMA
GB202308827D0 (en) Method of covering a portion of an object
KR102531024B9 (ko) 탈질설비의 필터 처리 방법
GB202119151D0 (en) Method of operating a pvd apparatus
GB202209379D0 (en) A method of creating an object
GB202313088D0 (en) Method of controlling a woodchipper apparatus
AU2023902084A0 (en) A method of treatment
AU2023900201A0 (en) A method of treatment
AU2022903614A0 (en) A method of treatment
AU2022901804A0 (en) A method of treatment
GB2591116B (en) Method of protecting a fixing
AU2021902898A0 (en) A method of treatment
AU2021902901A0 (en) A method of treatment
AU2021902899A0 (en) A method of treatment
AU2021902426A0 (en) A method of treatment
AU2021902404A0 (en) A method of treatment
HK40097067A (en) Method of treating amyloidosis
AU2021900847A0 (en) A method of treatment
AU2021900324A0 (en) A method of treatment
AU2021900241A0 (en) A method of treatment
AU2020904264A0 (en) A method of treatment
AU2020903985A0 (en) A method of treatment